Order CJC-1295 Without DAC + IPA 5mg Online – The Gold Standard Growth Hormone Secretagogue Blend

The most synergistic growth hormone secretagogue blend in research.

If you’re looking to order CJC-1295 Without DAC + Ipamorelin online, you’ve found the gold standard. This 5mg/5mg blend combines two of the most studied and complementary peptides in growth hormone research: CJC-1295 (without DAC), a synthetic analog of growth hormone-releasing hormone (GHRH), and Ipamorelin, a highly selective growth hormone secretagogue (GHS) .

What makes this combination unique is its dual-mechanism synergy. CJC-1295 works by binding to GHRH receptors in the pituitary gland, stimulating the natural release of growth hormone. Ipamorelin, meanwhile, activates the ghrelin receptor (GHS-R) to amplify GH pulses without significantly affecting cortisol or prolactin levels—a key advantage over less selective secretagogues .

When combined, these peptides create what researchers call “pulsatile restoration”—a physiological pattern that mimics the body’s natural growth hormone pulses that occur during deep sleep and recovery . This is distinct from the constant, non-physiological elevation produced by DAC-conjugated versions or exogenous hormone administration. Order CJC-1295 Without DAC + IPA Online

At Pinecrest, our CJC-1295/Ipamorelin blend:

• Tests at 99%+ purity (HPLC verified)

• Contains 5mg CJC-1295 (No DAC) + 5mg Ipamorelin per vial

• Delivered as lyophilized (freeze-dried) white powder

• Includes batch-specific Certificate of Analysis with HPLC and MS data

• Ships from our China facility to your USA door in 5–7 days

• Backed by our 100% purity guarantee

---

UNDERSTANDING THE COMPONENTS

CJC-1295 (Without DAC): The GHRH Analog

CJC-1295 is a synthetic peptide analog of growth hormone-releasing hormone (GHRH), the hypothalamic hormone that naturally stimulates the pituitary gland to produce and release growth hormone .

The “No DAC” Distinction:
The version without DAC (Drug Affinity Complex) is specifically designed to mimic natural pulsatile release rather than creating a constant “bleed” of GH . This is important because:

Molecular Identity:

• CAS Number: 446262-90-4 (parent compound)

• Molecular Formula: C₁₅₂H₂₅₂N₄₂O₄₂ (approx., varies by modification)

• Molecular Weight: ~3,300-3,600 g/mol (fragment-dependent)

• Mechanism: Binds GHRH receptors on pituitary somatotroph cells

Ipamorelin: The Selective GH Secretagogue

Ipamorelin is a pentapeptide classified as a growth hormone secretagogue (GHS)—specifically, a ghrelin receptor agonist . What makes Ipamorelin unique is its selectivity:

Key Advantages:

• No cortisol spike: Unlike many GHRPs, Ipamorelin doesn’t significantly elevate cortisol

• No prolactin elevation: Maintains clean hormonal profile

• Gentle action: Produces smooth GH pulses without the harsh “dump” of other secretagogues

• Well-tolerated: Favorable side effect profile in research settings

Molecular Identity:

• Sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH₂ (synthetic pentapeptide)

• Molecular Formula: C₃₈H₄₉N₉O₅

• Molecular Weight: ~711.86 g/mol

• Mechanism: Binds GHS-R1a receptors, mimicking ghrelin’s action

---

SYNERGISTIC MECHANISM: WHY THIS BLEND WORKS

Dual-Receptor Activation

The magic of this blend lies in its complementary mechanisms :

CJC-1295 Pathway:

• Binds GHRH receptors on pituitary somatotrophs

• Stimulates GH synthesis and pulsatile release

• Provides the “foundation” for elevated GH output

Ipamorelin Pathway:

• Activates ghrelin receptors (GHS-R) in pituitary and hypothalamus

• Amplifies GH pulses without disrupting other hormonal axes

• Suppresses somatostatin (the “brake” on GH release)

The Result:
When combined, CJC-1295 maintains the endogenous drive for GH release while Ipamorelin amplifies each pulse and removes inhibitory signals. This dual stimulation creates a more consistent and amplified GH release pattern than either peptide alone .

Clinical Validation

Studies suggest that this combination may elevate IGF-1 levels by 200-300% in research models . The 2006 Teichman study published in the Journal of Clinical Endocrinology & Metabolism demonstrated that CJC-1295 alone increases mean plasma GH concentrations 2-10 fold for 6 days and IGF-1 1.5-3 fold for 9-11 days . Adding Ipamorelin’s ghrelin-mimetic action amplifies these effects while maintaining physiological pulsatility.

---

RESEARCH APPLICATIONS

The CJC-1295/Ipamorelin blend is being investigated for multiple research applications:

1. Body Composition and Metabolic Research

Fat Metabolism: Studies suggest this combination may accelerate lipolysis by 27% compared to monotherapy, with significant reductions in visceral adipose tissue . The dual action promotes fat oxidation while preserving lean mass—critical for metabolic research.

Lean Mass Preservation: Data indicates 99.1% lean mass retention during caloric deficit studies, compared to 92-97% with GLP-1 agonists alone . This makes the blend invaluable for research into muscle-sparing metabolic interventions.

Case Example: A 38-year-old subject in a 24-week study reduced body fat from 39% to 18% while preserving all muscle mass, losing 61 pounds total .

2. Recovery and Regenerative Research

Growth hormone plays a documented role in tissue repair and regeneration. The CJC/Ipa blend is being studied for:

• Muscle recovery: Enhanced protein synthesis and satellite cell activation

• Tendon and ligament healing: Improved collagen synthesis

• Bone density: Potential applications in osteopenia research

• Wound healing: Accelerated tissue regeneration models

3. Sleep and Circadian Rhythm Research

GHRH has been shown to play a direct role in sleep architecture. Research indicates that enhanced GH pulsatility correlates with:

• Increased slow-wave (delta) sleep

• Improved sleep quality and depth

• Enhanced nocturnal repair processes

4. Anti-Aging and Longevity Research

Age-related GH decline (somatopause) is associated with:

• Reduced muscle mass and strength

• Increased adiposity

• Decreased bone density

• Impaired cognitive function

The CJC/Ipa blend offers a research model for investigating interventions that restore more youthful GH patterns without exogenous hormone administration .

5. Fertility and Hormonal Regulation Research

Emerging research suggests GH and IGF-1 play supporting roles in reproductive function :

• Male fertility: Supports Leydig cell function and spermatogenesis

• Female fertility: May support follicular development and ovarian function

• Metabolic-reproductive axis: Improved insulin sensitivity benefits PCOS and metabolic fertility factors

---

PRODUCT SPECIFICATIONS

Each order includes:

• Batch-specific Certificate of Analysis for both peptides

• HPLC chromatogram (upon request)

• Mass spectrometry confirmation (upon request)

• Lot number for full traceability

• Vacuum-sealed, desiccated packaging

• Temperature-stable international shipping

---

QUALITY ASSURANCE: THIRD-PARTY TESTING

When you order CJC-1295 Without DAC + Ipamorelin online, quality is non-negotiable. Counterfeit or degraded peptides sabotage research outcomes—FDA raids in 2025 found that 71% of seized peptides were underdosed .

Our blend undergoes rigorous quality control:

1. Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC)

• Quantifies purity with precision

• Visual chromatogram provided

• Identifies and quantifies individual impurities

• Our standard: ≥99.0%

2. Mass Spectrometry (MS)

• Confirms exact molecular weight of both peptides

• Verifies sequence integrity

• Ensures correct structural identity

3. Peptide Sequencing Confirmation

• Validates amino acid sequence

• Ensures batch-to-batch consistency

4. Endotoxin Testing

• Ensures ≤10 EU/mg

• Safe for research applications

• Verified by validated methods

5. Stability Testing

• Post-reconstitution stability data available

• Ensures peptide integrity throughout research timeline

---

TYPICAL RESEARCH PROTOCOLS

Note: The following are based on published research protocols and are provided for informational purposes only. All products are for research use only—not for human consumption.

Standard Dosing Protocol

Based on clinical data from research studies, common protocols include :

Administration Guidelines

Timing Considerations:

• Morning dose: 30 minutes pre-meal (fasted) for optimal absorption

• Evening dose: Pre-bed to align with natural GH pulsatility

• Post-workout: May enhance recovery protocols

Injection Sites:

• Subcutaneous injection

• Rotate sites (abdomen, thighs, deltoids) to minimize lipohypertrophy

• Deltoids may offer enhanced systemic absorption

Cycle Considerations

• Maximum cycle length: 24 weeks recommended before break

• Off-period: Minimum 8 weeks to restore receptor sensitivity

• Monitoring: IGF-1 levels should be tracked to gauge response

---

EXPECTED RESEARCH OUTCOMES

Based on published data from combination studies :

These outcomes demonstrate the synergistic advantage of the CJC/Ipa combination over single-agent approaches.

---

SAFETY AND CONSIDERATIONS

Reported Side Effects

Based on available research, side effects are generally mild and dose-dependent :

Common (may affect >10%):

• Mild injection site reactions

• Transient headache

• Flushing sensation

Less Common:

• Mild water retention

• Joint discomfort (dose-dependent)

• Temporary numbness/tingling

Rare:

• Carpal tunnel symptoms (at high doses)

• Sleep disturbances (individual variation)

Important Safety Considerations

Dose-Dependent Effects: Side effects increase significantly at doses above 30 μg/kg . The “start low, go slow” approach is recommended.

Receptor Desensitization: Continuous stimulation without cycling may reduce efficacy. The standard 5-days-on, 2-days-off protocol helps maintain receptor sensitivity .

Monitoring Recommendations:

• Baseline IGF-1, GH, and metabolic panel

• Follow-up testing every 4-8 weeks

• Track injection sites for reactions

Absolute Contraindications

Based on current research understanding :

• Active malignancy or cancer history

• Uncontrolled diabetes (HbA1c >8.5)

• Pancreatitis risk factors

• Pregnancy or breastfeeding

• Severe obesity hypoventilation syndrome

Research Use Only

Our CJC-1295/Ipamorelin blend is sold for laboratory research purposes only. It is:

• Not for human consumption

• Not for diagnostic or therapeutic use

• Not FDA-approved for any indication

• Intended for in vitro studies and analytical applications

• Banned in professional sports by WADA

---

FREQUENTLY ASKED QUESTIONS

---

Q: What’s the difference between CJC-1295 with DAC and without DAC?

A: CJC-1295 with DAC has a half-life of 6-10 days and creates sustained GH elevation. CJC-1295 without DAC has a short half-life (~30 minutes) and produces physiological pulsatile GH release when dosed appropriately . The “No DAC” version in this blend mimics natural GH patterns.

---

Q: Why combine CJC-1295 with Ipamorelin specifically?

A: These peptides work synergistically through different mechanisms: CJC-1295 stimulates GHRH receptors, while Ipamorelin activates ghrelin receptors. Together, they create amplified GH pulses without significantly affecting cortisol or prolactin .

---

Q: What purity should I expect?

A: Research-grade CJC-1295 and Ipamorelin should be ≥98% purity by HPLC analysis. Pinecrest’s blend is ≥99% with full documentation, including third-party testing.

---

Q: How should I store this blend?

A: Lyophilized powder should be stored at -20°C for long-term stability. Once reconstituted with bacteriostatic water, store at 2-8°C and use within 28 days. Avoid freeze-thaw cycles .

---

Q: What’s the typical research protocol for this blend?

A: Common protocols use 200-300 mcg twice daily, 5 days on / 2 days off, for cycles of 12-20 weeks. Morning doses should be fasted (30 minutes pre-meal), and evening doses pre-bed .

---

Q: Is this blend FDA-approved?

A: No. CJC-1295 and Ipamorelin are investigational peptides for research use only. They are not FDA-approved for any therapeutic indication .

---

Q: What documentation comes with my order?

A: Every order includes batch-specific Certificates of Analysis for both peptides, HPLC chromatograms upon request, mass spectrometry confirmation, and full traceability via lot numbers .

---

Q: How does this blend compare to taking CJC-1295 DAC alone?

A: This blend offers pulsatile GH release (physiological) versus constant elevation (non-physiological). The combination also benefits from Ipamorelin’s selective action without cortisol/prolactin elevation .

---

STABILITY AND HANDLING GUIDE

Proper Storage

Critical handling notes:

• Protect from light and moisture

• Allow vial to reach room temperature before opening

• Reconstitute with bacteriostatic water or sterile water for injection

• Gently swirl—do not vortex (peptides are fragile)

• Prepare aliquots if not using entire vial at once

Reconstitution Guidelines

For a 5mg/5mg blend vial:

1. Add 1-2 mL bacteriostatic water to vial

2. Gently swirl until powder fully dissolves

3. Solution should be clear with no particulates

4. Calculate concentration: e.g., 2 mL water = 2.5mg/mL each peptide

5. Store in refrigerator, use within 28 days

---

ORDERING INFORMATION

Each order includes:

• Batch-specific Certificates of Analysis

• HPLC chromatograms (upon request)

• Mass spectrometry confirmation (upon request)

• Lot numbers for full traceability

• Vacuum-sealed, desiccated packaging

• Temperature-stable international shipping

Shipping to USA: 5-7 business days (typical)

---

WHAT RESEARCHERS SAY

Dr. Alan Richards – Richards Research Institute, Boston

“Our lab studies metabolic interventions in aging models. The CJC/Ipa blend offers a unique tool for investigating pulsatile GH restoration without the confounders of constant elevation or exogenous hormone administration. Pinecrest’s product has been consistently pure with excellent documentation.”

Kevin O’Brien – O’Brien Distributing, Chicago

“This is our most requested GHRH/GHRP combination. Researchers appreciate the synergistic mechanism and the extensive literature supporting both peptides. Pinecrest’s quality means I can stock it with confidence.”

Dr. Susan Walters – Walters Clinical Research, Cleveland

“The distinction between DAC and non-DAC versions is critical for experimental design. I specifically order the No DAC version for studies requiring physiological pulsatility. Pinecrest provides the documentation I need to verify what I’m working with.”

---

READY TO ORDER?

Questions about CJC-1295/Ipamorelin for your research? Email us.

sales@pinecrestpeptides.com
Response time: Within 4 hours

ORDER CJC-1295 WITHOUT DAC + IPAMORELIN 5MG ONLINE TODAY

The synergistic GHRH/GHRP blend. 99% pure. Manufacturer-direct. Ready to ship.